Document jB7m2vmJLxq6MDk9EQVDENDy
US EPA OR J Toxicity of PFA
I
' w rrrr ' ' - ^ / /
L
Mi
Uliixlil
US EPA Office of Rt National Center fo
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
*' ' : * -*S
+< It
* .' ' .* `T*. * .
'
'
* <
^ t
* X
*& &. -i*;%:m
**
*
*
x **
*
.
&
'
ED 002061 00269050-00001
Problem formulation:
- Hundreds to thousands of untested PFAS in the environmem - Traditional single-chemical toxicity testing not practical or efficient - Toxicity and toxicokinetic information needed to inform decision
making
How do we generate informative toxicity and kinetic information quickly?
- EPA ORD, National Toxicology Program (NTP) and partners have the capacity to generate toxicity and toxicokinetic data through high throughput methods (HTT) assays
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED 002061 00269050-00002
Procure a library of "300-400 PFAS (PFAS Screening Library) to support development of analytical methods, environmental monitoring, and toxicity testing
Define a reference subset of "75 PFAS based on:
-- Conduct tiered toxicity and toxicokinetic testing chemicals within the PFAS landscape
- Data will support multiple outputs, making use of the integrated dataset (in vivo, in vitro, etc.) to inform toxicity and kinetics across the PFAS landscape
Not for Release
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED 002061 00269050-00003
EPA DSSTox Database: > 758K chemicals
Span nin g public II <v interest to ERA
-? 'tocmpt to procure hmmeals w/ structures)
i 'FAS Screening Library (procurements in-process)
S of interest to ERA
osure, occurrence, tox data)
-2* '' Reference subset {tiered toxicity & toxicokinetic testing)
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
EPA
'Rfluorinated alkyl substances (PFAS) ;mical names, acronyms, synonyms mical structure categories
ED 002061 00269050-00004
Tier 1
In Vitro Toxicity and
Toxicokinetic Assays
-7 5 Reference PFAS
Human Exposure Characterization
High Potential Risk
Tier 2
In Vivo Toxicological and
Toxicokinetic Assays
*Collaboration between EPA and NTP
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED 002061 00269050-00005
PFAS potency estimations: Primary outputs will be administered dose equivalents (ADE) and Bioactivity-toexposure ratio (BER)
-- Characterization of uncertainty is critical to decision context
Communicate characteristics for Tier I data to partners and stakeholders in advance for use-considerations in different decision making contexts
Prioritize PFAS for Tier 2 in vivo testing
Mot for Release
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
S
ED 002061 00269050-00006
ORD Medium Throughput Research Studies
Mot for Release
Club v. EPA 18cv3472 NDCA
Tier 10
h
ED 002061_00269050-00007
Established model of vertebrate embryonic d e ve lo p m e n t
Rapid, external d e ve lo p m e n t
~75% o f genes have human homologs
Transparent
Transgenics, mutants Amenable to chemical screening
Not for Release
Sierra Club v. EPA 18cv3472 NDCA
S ________
0-24 hpf; Karlstrom etal. Dev. 1996.
Tal et a!. Repro Tox. 2015.
Tamara Tal, U.S. EPA
Tier 10
ED_002061_00269050-00008
One embryo seeded per well o f a 96 well plate
Exposed daily (days 0-5) to 8 PFAS compounds
On day 6:
- DevTox: Malformations and lethality
- Dev Neurotoxicity (DNT): Behavioral
activity as afunctional readout of DNT - Toxicokinetics: Determine parent and chemical metabolite tissue dose using targeted analytical chemistry and non-targeted analysis
r+T+--H r- r F f f F FF? F - F
Not for Release
Sierra Club v. EPA 18cv3472 NDCA
Tamara Tal, U.S. EPA
Tier 10
r? o
p
r r ? r-
"l f'
PFHsA r- : 7 r F
PFM xS F * F < f Vf \
GertX A cid r
; > f."Vv
1
V
f "
^
"
GertX Saft w T F . 'y o
> ' A ' P r ./' 'f y i F" V V
/
i
i
ADONA
Fv . " - - , ; ' f 1 J A
t' V F F ' - t
afien P 1
F -V
sf 0 --i-- j . .. :y .
F- X f X F
f 'F
ED 002061 00269050-00009
Study on the effects of GenX in the fetal and pregnant Charles River Laboratories (CRSD) rat
Pilot study on the effects of in utero GenX in the F I male
and female rat offspring using a one generation screening protocol
In vitro studies of potential agonist and antagonist interactions with the following steroid receptors Androgen receptor (Chimpanzee) Estrogen receptor (ER a) Glucocorticoid receptor (hGR)
for Release
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED 002061 00269050-00010
Toxicity and toxicokinetic testing Ongoing research Integration with risk assessment efforts
Mot for Rcilooso
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
4 1 AV
ED 002061_00269050-00011
EPA
NIEHS/NTP
- John Bucher - Chad Blystone - Mike DeVito - Sue Fenton - Dori Germolec - Eric Tokar
US EPA
- Rusty Thomas - Kevin Crofton - Tina Bahadori - Jeff Frithsen - Amy Benson - Susan Burden - Lynn Flowers - Linda Gaines
US EPA (continued)
- Andy Gillespie - Earl Gray - Maureen Gwinn - Ron Hines - Jason Lambert - Pam Noyes - Grace Patlewicz - Stephanie Padilla - Ann Richard - Bruce Rodan - Tim Shafer - Mark Strynar - Tamara Tal - Barbara Wetmore
and many others....
Disclaimer: The views expressed in this presentation are that of the presenters and do not necessarily represent the views and/or
policies of the U.S. Environmental Protection Agency.
^
*
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED 002061 00269050-00012
Additional Slides
Not tor Release
Sierra Club v. EPA 18cv3472 NDCA
Tier 10
ED_002061_00269050-00013
Endpoint of Interest
W
Hepatotoxicity
Developmental Toxicity Immunotoxicity
Mitochondrial Toxicity
Developmental Neurotoxicity
2D HepaRG cytotoxicity; 3D HepaRG (spheroid) transcriptomics
Bioseek Immune panel
2D HepaRG mitochondrial dye and Seahorse assay
Sierra Club v. EPA 18cv3472 NDCA
Tier
National Center for Computational Toxicology (NCCT)
Attagene cis- and trans- Factorial assay (HepG2)
National Health and Environmental Effects Research Laboratory
(NHEERL)
Zebrafish embryo assay
Neurodevelopmental microelectrode assay
10
ED 002061 00269050-00014
mai n i n m H m n
Human primary hepatocyte clearance
Renal proximal tubule permeability assay
In Vitro Disposition Cell vs. nominal concentration (Tox21 joint project)
O $> i:"
5;%:di v?'%i:
Sierra Club v. EPA 18cv3472 NDCA
EPA
National Center for
National Health and
Computational
Environmental Effects
Toxicology
Research Laboratory
(NCCT)
(NHEERL)
Ultracentrifugation assay
Piloting hepatic transporter assay
Cell vs. nominal concentration (Tox21 joint project)
Tier 10
ED 002061 00269050-00015